A Single Centre Randomized Study Evaluating The Safety And Tolerability Of GSK233705 In Healthy Volunteers.

Status:
Completed

Trial end date:
2007-05-16

Target enrollment:

Participant gender:

This study will investigate the safety and tolerability of inhaled doses of GSK233705 with a new formulation.

Phase 1

GlaxoSmithKline